Unilateral mydriasis in a child with a ventriculoperitoneal shunt for obstructive hydrocephalus: a diagnostic dilemma

Monidipa Banerjee1, Eiman Haj Ahmed1, Kathryn Foster1

  • 1Department of Paediatrics, Ysbyty Gwynedd, Bangor, UK.

BMJ Case Reports
|December 29, 2020
PubMed

Insights

Sudden unilateral mydriasis in a child with a VP shunt was caused by ipratropium bromide nebulizer treatment. This reversible adverse effect highlights the need to consider medication side effects in diagnosis.

Area of Science:

  • Pediatric Neurology
  • Pharmacology
  • Ophthalmology

Background:

  • Unilateral mydriasis can indicate serious conditions like transtentorial uncal herniation.
  • Ventriculoperitoneal (VP) shunts are used to treat obstructive hydrocephalus in children.
  • Pharmacological causes of anisocoria (unequal pupil size) must be considered in differential diagnoses.

Observation:

  • A 3-year-old boy with a VP shunt for hydrocephalus developed acute respiratory distress.
  • During nebulizer treatment, he presented with unilateral mydriasis and absent light reflex.
  • Initial CT scan showed no new intracranial abnormalities.

Findings:

  • The condition was diagnosed as pharmacological anisocoria, specifically ipratropium-induced.
  • Symptoms resolved completely within 24 hours after discontinuing ipratropium bromide.
  • This is a rare presentation in a child with a VP shunt.

Implications:

  • Clinicians must urgently evaluate unilateral mydriasis, considering both life-threatening conditions and medication side effects.
  • Ipratropium bromide, especially via ill-fitting masks, can cause reversible anisocoria in children.
  • This case underscores the importance of a thorough medication history in pediatric neurological emergencies.